Sign In
Buy PFE
$25.69
+0.335 (+1.32%)
At Close: Jun 04, 2026
Mizuho's Jared Holz on Merck and Pfizer Q4 results, 2025 outlook for Big Pharma stocks
08:35am, Tuesday, 04'th Feb 2025
Jared Holz, Mizuho Securities America healthcare sector strategist, joins 'Squawk Box' to break down the quarterly earnings results of Merck and Pfizer, 2025 outlook for pharmaceutical stocks, and mor
Pfizer stock climbs on Q4 revenue and earnings beat, reaffirmed guidance
08:22am, Tuesday, 04'th Feb 2025
“We remain confident in our ability to return to pre-pandemic operating margins in the coming years,” said Pfizer CFO David Denton.
Pfizer tops earnings estimates as Covid product sales beat expectations and cost cuts pay off
07:12am, Tuesday, 04'th Feb 2025
Pfizer reported fourth-quarter earnings and revenue that beat estimates as sales of the company's Covid products came in higher than expected and cancer drugs from Seagen boosted revenue. The results
Pfizer beats fourth-quarter profit estimates on cost-cutting efforts
06:53am, Tuesday, 04'th Feb 2025
U.S. drugmaker Pfizer beat Wall Street estimates for fourth-quarter profit on Tuesday, helped by cost-cutting efforts and better-than-expected sales of its COVID vaccine.
Pfizer Reports Strong Full-Year 2024 Results And Reaffirms 2025 Guidance
06:45am, Tuesday, 04'th Feb 2025
NEW YORK--(BUSINESS WIRE)--Pfizer Fourth-Quarter and Full-Year 2024 Earnings Release.
2 Ultra-High-Yield Dividend Stocks That Are No-Brainer Buys in February
05:06am, Tuesday, 04'th Feb 2025
For more than a century, the stock market has stood tall over all other asset classes. While buying and holding bonds, gold, oil, or real estate, would have increased your wealth, no asset class has c
Pfizer Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
04:15am, Tuesday, 04'th Feb 2025
Pfizer Inc. PFE will release its fourth-quarter financial results, before the opening bell, on Tuesday, Feb. 4, 2025.
Merck Vs. Pfizer: Which Pharmaceutical Giant Will Prevail In Q4 Earnings?
01:49pm, Monday, 03'rd Feb 2025
Merck & Co Inc MRK and Pfizer Inc PFE are duking it out for investor attention with fourth-quarter earnings being reported on Tuesday.
Will These 5 Big Drug Stocks Surpass Q4 Earnings Forecasts?
12:20pm, Monday, 03'rd Feb 2025
Let's look at five pharma and drug companies, MRK PFE, LLY, AMGN and BMY, which are scheduled to release their fourth-quarter 2024 results later this week.
Will Non-COVID Drugs Drive PFE's Top Line in Q4 Earnings?
11:56am, Monday, 03'rd Feb 2025
Pfizer's non-COVID drugs and contributions from new and newly acquired products are likely to have driven top-line growth in the fourth quarter.
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of BRAFTOVI® (encorafenib
Smaller US winter COVID wave adds pressure to Pfizer turnaround
06:03am, Monday, 03'rd Feb 2025
Health experts are seeing signs of a much smaller wave of U.S. COVID-19 cases this winter than in previous years, which could put additional pressure on Pfizer to find growth from its non-COVID treatm
Pfizer resolves conservative challenge to diversity fellowship program
05:25pm, Friday, 31'st Jan 2025
Pfizer has resolved a lawsuit by a conservative group that alleged that a fellowship program that the drugmaker established to boost the pipeline of Black, Latino and Native American people in leaders
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know
10:01am, Friday, 31'st Jan 2025
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Pfizer (PFE) is a Top-Ranked Momentum Stock: Should You Buy?
10:51am, Thursday, 30'th Jan 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
